United Therapeutics is a biotechnology company focused on combating cardiovascular, inflammatory and infectious diseases with unique therapeutic products. United Therapeutics Corp. has a market cap of $2.52 billion; its shares were traded at around $43.24 with a P/E ratio of 14.32 and P/S ratio of 4.18.
CEO of United Therapeutics Martine A. Rothblatt recently bought more than $100,000 worth of the company. On Dec. 16, 2011, Rothblatt purchased 12,701 shares of the company at an average price of $42.45. The total transaction amount was $539,157.
Previously, Rothblatt has been steadily increasing his stake in United Therapeutics throughout the month of December 2011. Rothblatt made trades on December 6, 8, 12, 14 and 16, each time purchasing over 12,000 shares of the company, at around the price of $42 per share.
Martine Rothblatt graduated from the University of California, Los Angeles, in 1981 with a combined law degree and MBA. He is a lawyer, author and entrepreneur. In addition to serving as CEO of United Therapeutics, he founded several communications satellite companies, including GeoStar, WorldSpace and Sirius Satellite Radio.
Joel Greenblatt owns 65,122 shares of United Therapeutics as of 09/30/2011, an increase of 274.82% from the previous quarter. This position accounts for 0.3977% of the $614 million portfolio of Gotham Capital. Edward Owens owns 1,787,000 shares as of 09/30/2011, an increase of 77.9% from the previous quarter. This position accounts for 0.3654% of the $18.34 billion portfolio of Vanguard Health Care Fund. George Soros sold out his holdings in the quarter that ended on 09/30/2011. Michael Price sold out his holdings in the quarter that ended on 09/30/2011.
While Rothblatt has been steadily increasing his stake in UTHR, other insiders have been selling off their shares. CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 08/04/2011 at the average price of $51.01. The price of the stock has decreased by 15.23% since. President and COO Roger Jeffs sold 5,000 shares of UTHR stock on 08/05/2011 at the average price of $50.77. Roger Jeffs owns at least 22,062 shares after this. The price of the stock has decreased by 14.83% since. Other insiders have also reduced their positions in the company.
CEO of United Therapeutics Martine A. Rothblatt recently bought more than $100,000 worth of the company. On Dec. 16, 2011, Rothblatt purchased 12,701 shares of the company at an average price of $42.45. The total transaction amount was $539,157.
Previously, Rothblatt has been steadily increasing his stake in United Therapeutics throughout the month of December 2011. Rothblatt made trades on December 6, 8, 12, 14 and 16, each time purchasing over 12,000 shares of the company, at around the price of $42 per share.
Martine Rothblatt graduated from the University of California, Los Angeles, in 1981 with a combined law degree and MBA. He is a lawyer, author and entrepreneur. In addition to serving as CEO of United Therapeutics, he founded several communications satellite companies, including GeoStar, WorldSpace and Sirius Satellite Radio.
Joel Greenblatt owns 65,122 shares of United Therapeutics as of 09/30/2011, an increase of 274.82% from the previous quarter. This position accounts for 0.3977% of the $614 million portfolio of Gotham Capital. Edward Owens owns 1,787,000 shares as of 09/30/2011, an increase of 77.9% from the previous quarter. This position accounts for 0.3654% of the $18.34 billion portfolio of Vanguard Health Care Fund. George Soros sold out his holdings in the quarter that ended on 09/30/2011. Michael Price sold out his holdings in the quarter that ended on 09/30/2011.
While Rothblatt has been steadily increasing his stake in UTHR, other insiders have been selling off their shares. CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 08/04/2011 at the average price of $51.01. The price of the stock has decreased by 15.23% since. President and COO Roger Jeffs sold 5,000 shares of UTHR stock on 08/05/2011 at the average price of $50.77. Roger Jeffs owns at least 22,062 shares after this. The price of the stock has decreased by 14.83% since. Other insiders have also reduced their positions in the company.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
